Descriptive Epidemiology of Malaria in Afghanistan
Analysis of Recorded Data from 2000 to 2024
DOI:
https://doi.org/10.61438/sarj.v2i1.153Keywords:
malaria, epidemiology, plasmodium vivax, malaria control, AfghanistanAbstract
Objectives: This study aims to provide a descriptive epidemiological analysis of malaria in Afghanistan from 2000 to 2024, focusing on demographic, geographical, and seasonal patterns. The research investigates trends in malaria incidence to inform future public health interventions.
Methods: A narrative review study was conducted using malaria reports data collected by WHO and MoPH of Afghanistan. The data included reported malaria cases (suspected, confirmed and death cases - p.falciparum and p.vivax cases), demographic distribution, and seasonal reports. Statistical analysis was performed to identify trends and high-risk regions over the study period.
Results: Between 2000 and 2024, Afghanistan reported approximately 3.67 million confirmed malaria cases and 19.67 million suspected cases, with an estimated annual average of 152 confirmed cases per 100,000 people. The incidence rate fluctuated, peaking in 2002 with 414,611 confirmed cases and declining significantly after 2019 due to strengthened intervention strategies. The most affected provinces in 2024 were Nuristan (396.5), Kunar (284.8), and Laghman (174.2) per 10,000. Among reported cases, 92.2% were caused by Plasmodium vivax and 6.5% by Plasmodium falciparum. The mortality rate over the 24-year period was approximately 0.04 deaths per 100,000 people annually.
Conclusion: Despite a decline in malaria incidence due to control measures, Afghanistan remains an endemic region, with certain provinces experiencing persistent transmission. Strengthening healthcare infrastructure, expanding vector control programs, and enhancing community-based interventions are crucial for further reducing the malaria burden. Future efforts should focus on improving diagnostic facilities, addressing drug resistance, and integrating innovative technologies for malaria surveillance and prevention.
References
[1] Siddiqui JA, Aamar H, Siddiqui A, Essar MY, Khalid MA, Mousavi SH. Malaria in Afghanistan: Challenges, efforts and recommendations. Ann Med Surg 2022;81. https://doi.org/10.1016/j.amsu.2022.104424.
[2] WHO. Malaria 2025. https://www.who.int/health-topics/malaria (accessed April 6, 2025).
[3] Cox FE. History of the discovery of the malaria parasites and their vectors. Parasit Vectors 2010;3:5. https://doi.org/10.1186/1756-3305-3-5.
[4] Arrow KJ, Panosian C, Gelband H. A Brief History of Malaria. Sav. Lives Buy. Time Econ. Malar. Drugs Age Resist., National Academies Press (US); 2004.
[5] WHO. Fact sheet about malaria 2024. https://www.who.int/news-room/fact-sheets/detail/malaria (accessed April 6, 2025).
[6] Geain C. Overview of the Different Types of Malaria Endemicity. Jounal Torpical Dis Public Health 2023. https://doi.org/10.35248/2329-891X.23.11.406.
[7] Tan K, Abanyie F. Malaria | CDC Yellow Book 2024 n.d. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/malaria (accessed April 5, 2025).
[8] Li C, Wu X, Cheng X, Fan C, Li Z, Fang H, et al. Identification and analysis of vulnerable populations for malaria based on K-prototypes clustering. Environ Res 2019;176:108568. https://doi.org/10.1016/j.envres.2019.108568.
[9] Gorgas WC, Youyou T, Ross SR, Lancisi GM, Laveran A. Malaria | Causes, Symptoms, Treatment, & Prevention | Britannica 2025. https://www.britannica.com/science/malaria (accessed April 5, 2025).
[10] NSW. Malaria factsheet 2024.
[11] Mertens JE. A History of Malaria and Conflict. Parasitol Res 2024;123:165. https://doi.org/10.1007/s00436-024-08167-4.
[12] Menard D, Dondorp A. Antimalarial Drug Resistance: A Threat to Malaria Elimination. Cold Spring Harb Perspect Med 2017;7:a025619. https://doi.org/10.1101/cshperspect.a025619.
[13] Mahmoodi SD, Atarud AA, Sediqi AW, Gallalee S, McFarland W, Aynie TB, et al. Trends in malaria indicators after scale-up of community-based malaria management in Afghanistan. Malar J 2022;21:165. https://doi.org/10.1186/s12936-022-04174-x.
[14] Kolaczinski J, Graham K, Fahim A, Brooker S, Rowland M. Malaria control in Afghanistan: progress and challenges. The Lancet 2005;365:1506–12. https://doi.org/10.1016/S0140-6736(05)66423-9.
[15] Mahmoodi SD. How a Community-Based Strategy helped reduce Malaria in Afghanistan. UNDP n.d. https://www.undp.org/afghanistan/blog/how-community-based-strategy-helped-reduce-malaria-afghanistan (accessed April 5, 2025).
[16] Darivoa. Malaria cases in Afghanistan have increased by 69 percent. VOA 2024. https://www.darivoa.com/a/malaria-cases-in-afghanistan-rise-by-69-per-cent/7688968.html (accessed April 5, 2025).
[17] MOPH. NATIONAL STRATEGIC PLAN “FROM MALARIA CONTROL TO ELIMINATION IN AFGHANISTAN” 2018-2022 2017.
[18] APMEN. Afghanistan National Strategic Plan to Control Malaria (2023-2026) | APMEN 2023. https://apmen.org/resources/afghanistan-national-strategic-plan-control-malaria-2023-2026 (accessed April 5, 2025).
[19] WHO. World malaria report 2015 2015. https://www.who.int/publications/i/item/9789241565158 (accessed April 20, 2025).
[20] WHO. World malaria report 2024: addressing inequity in the global malaria response. World Health Organization; 2024.
[21] WHO. World malaria report 2023 2023. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023 (accessed April 20, 2025).
[22] WHO. Malaria. World Health Organ - Reg Off East Mediterr 2024. http://www.emro.who.int/afg/programmes/malaria-leishmaniasis.html (accessed April 20, 2025).
[23] Jackson A. Explainer: How climate change is amplifying mosquito-borne diseases. World Mosq Program 2022. https://www.worldmosquitoprogram.org/en/news-stories/stories/explainer-how-climate-change-amplifying-mosquito-borne-diseases (accessed April 5, 2025).
[24] Colonia CB, Vásquez-Rodríguez AB, Alexander N, de la Hoz Restrepo F. Malaria, relationship with climatic variables and deforestation in Colombia, Latin America and the Caribbean from 2000 to 2020: a systematic review. Malar J 2024;23:347. https://doi.org/10.1186/s12936-024-05140-5.
[25] Wagemaker S, Schwaab I, Feres B, Soares M, Orlandi G. Healthcare Challenges And Covid 19 Pandemic In Afghanistan - A Political And Social Perspective 2022.
[26] Leslie T, Mikhail A, Mayan I, Anwar M, Bakhtash S, Nader M, et al. Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study. BMJ 2012;345:e4389–e4389. https://doi.org/10.1136/bmj.e4389.
[27] Alegana VA, Wright JA, Nahzat SM, Butt W, Sediqi AW, Habib N, et al. Modelling the Incidence of Plasmodium vivax and Plasmodium falciparum Malaria in Afghanistan 2006–2009. PLoS ONE 2014;9:e102304. https://doi.org/10.1371/journal.pone.0102304.
[28] Nemat A, Sherzad AG, Ehsan E, Hussainzai A, Naderi M, Zaki N, et al. Knowledge, attitude, and practices toward malaria among hospital outpatients in Nangarhar, Afghanistan: A cross-sectional study. SAGE Open Med 2024;12:20503121241251758. https://doi.org/10.1177/20503121241251758.
[29] Howard N. Malaria control for Afghans in Pakistan and Afghanistan (1990-2005): a mixed-methods assessment considering effectiveness, efficiency, equity, and humanity 2017. https://doi.org/10.17037/PUBS.04646629.
[30] Bruxvoort KJ, Leurent B, Chandler CIR, Ansah EK, Baiden F, Björkman A, et al. The Impact of Introducing Malaria Rapid Diagnostic Tests on Fever Case Management: A Synthesis of Ten Studies from the ACT Consortium. Am J Trop Med Hyg 2017;97:1170–9. https://doi.org/10.4269/ajtmh.16-0955.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Salamat Academic & Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
